OMNIBUS AMENDMENT NO. 1 TO2021 Note Financing Agreements • April 8th, 2022 • Intrinsic Medicine, Inc. • Biological products, (no disgnostic substances) • Arizona
This Omnibus Amendment No. 1 to 2021 Note Financing Agreements (the “Amendment”), is between Intrinsic Medicine, Inc., a Delaware corporation, located at 500 Yale Avenue North, Seattle, WA 98109 (the “Company”), and the undersigned noteholders party hereto (each, a “Consenting Holder” and collectively, the “Consenting Holders”, and together with the Company, the “Parties”, and each, a “Party”) and is dated as of March 28, 2022.
